Search - tctmd.com

Displaying 141 - 160 of 392

Sort: Relevancy | Date

News Daily News

BRAIN 研究证实心脏病科医生左侧接受的放射剂量更多

Yael L. Maxwell

August 19, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Daily News

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

Todd Neale

July 13, 2015

News Daily News

FDA批准了一种具有生存优势的心力衰竭药物

Todd Neale

July 13, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

La Aprobación de la FDA de Cangrelor Amplía las Opciones Antiplaquetarias para la PCI

Todd Neale

June 29, 2015

News Daily News

FDA 批准坎格雷洛作为 PCI 的抗血小板治疗方案

Todd Neale

June 29, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

News Industry News

FDA approves new antiplatelet drug used during heart procedure

June 24, 2015

News Daily News

比伐卢定加 GPI 可减少接受 PCI 的心衰患者的出血和死亡率

June 09, 2015

News Daily News

Bivalirudina + GPI Reduce las Hemorragias y Mortalidad de Pacientes con ICC sometidos a PCI

June 09, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Daily News

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

June 04, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Daily News

El Pretratamiento con Ticagrelor podría No Proteger frente a la Mionecrosis Perioperatoria en el Manejo de cuadros de SCASEST

June 04, 2015

News Daily News

如何保证为接受直接 PCI 而转诊的 STEMI 患者能获得及时治疗仍是个难题

Todd Neale

June 01, 2015

Advertisement

BRAIN 研究证实心脏病科医生左侧接受的放射剂量更多

Lilly Provides Update on Evacetrapib Phase 3 Trial

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

FDA批准了一种具有生存优势的心力衰竭药物

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

La Aprobación de la FDA de Cangrelor Amplía las Opciones Antiplaquetarias para la PCI

FDA 批准坎格雷洛作为 PCI 的抗血小板治疗方案

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

FDA approves new antiplatelet drug used during heart procedure

比伐卢定加 GPI 可减少接受 PCI 的心衰患者的出血和死亡率

Bivalirudina + GPI Reduce las Hemorragias y Mortalidad de Pacientes con ICC sometidos a PCI

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

El Pretratamiento con Ticagrelor podría No Proteger frente a la Mionecrosis Perioperatoria en el Manejo de cuadros de SCASEST

如何保证为接受直接 PCI 而转诊的 STEMI 患者能获得及时治疗仍是个难题

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content